 | • レポートコード：D005-10366 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、メチルフェニデートの世界市場を広く調査・分析し、今後の市場展望をまとめております。メチルフェニデートの種類別市場規模（タイプ1、タイプ2）、用途別市場規模（注意欠陥多動性障害、ナルコレプシー、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Sandoz、Teva、Novartis、GSK ・地域別グローバル市場分析 2015年-2020年 ・メチルフェニデートの北米市場（アメリカ、カナダ、メキシコ） ・メチルフェニデートのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・メチルフェニデートのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・メチルフェニデートの南米市場（ブラジル、アルゼンチン） ・メチルフェニデートの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タイプ1、タイプ2 ・用途別分析：注意欠陥多動性障害、ナルコレプシー、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Methylphenidate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Methylphenidate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Methylphenidate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Methylphenidate market has been segmented into
Type 1
Type 2
By Application, Methylphenidate has been segmented into:
Attention deficit hyperactivity disorder
Narcolepsy
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Methylphenidate market presented in the report. This section sheds light on the sales growth of different regional and country-level Methylphenidate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Methylphenidate market.
The report offers in-depth assessment of the growth and other aspects of the Methylphenidate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Methylphenidate Market Share Analysis
Methylphenidate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Methylphenidate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Methylphenidate sales, revenue and market share for each player covered in this report.
The major players covered in Methylphenidate are:
Pfizer
Sandoz
Teva
Novartis
GSK
Among other players domestic and global, Methylphenidate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Methylphenidate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Methylphenidate, with price, sales, revenue and global market share of Methylphenidate in 2018 and 2019.
Chapter 3, the Methylphenidate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Methylphenidate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Methylphenidate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Methylphenidate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Methylphenidate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Methylphenidate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Type 1
1.2.3 Type 2
1.3 Market Analysis by Application
1.3.1 Overview: Global Methylphenidate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Attention deficit hyperactivity disorder
1.3.3 Narcolepsy
1.3.4 Other
1.4 Overview of Global Methylphenidate Market
1.4.1 Global Methylphenidate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sandoz SWOT Analysis
2.2.4 Sandoz Product and Services
2.2.5 Sandoz Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Methylphenidate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Methylphenidate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Methylphenidate Manufacturer Market Share in 2019
3.3.2 Top 6 Methylphenidate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Methylphenidate Sales, Revenue and Market Share by Regions
4.1.1 Global Methylphenidate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Methylphenidate Revenue and Market Share by Regions (2015-2020)
4.2 North America Methylphenidate Sales and Growth Rate (2015-2020)
4.3 Europe Methylphenidate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Methylphenidate Sales and Growth Rate (2015-2020)
4.5 South America Methylphenidate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Methylphenidate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Methylphenidate Sales, Revenue and Market Share by Country
5.1.1 North America Methylphenidate Sales and Market Share by Country (2015-2020)
5.1.2 North America Methylphenidate Revenue and Market Share by Country (2015-2020)
5.2 United States Methylphenidate Sales and Growth Rate (2015-2020)
5.3 Canada Methylphenidate Sales and Growth Rate (2015-2020)
5.4 Mexico Methylphenidate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Methylphenidate Sales, Revenue and Market Share by Country
6.1.1 Europe Methylphenidate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Methylphenidate Revenue and Market Share by Country (2015-2020)
6.2 Germany Methylphenidate Sales and Growth Rate (2015-2020)
6.3 UK Methylphenidate Sales and Growth Rate (2015-2020)
6.4 France Methylphenidate Sales and Growth Rate (2015-2020)
6.5 Russia Methylphenidate Sales and Growth Rate (2015-2020)
6.6 Italy Methylphenidate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Methylphenidate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Methylphenidate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Methylphenidate Revenue and Market Share by Regions (2015-2020)
7.2 China Methylphenidate Sales and Growth Rate (2015-2020)
7.3 Japan Methylphenidate Sales and Growth Rate (2015-2020)
7.4 Korea Methylphenidate Sales and Growth Rate (2015-2020)
7.5 India Methylphenidate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Methylphenidate Sales and Growth Rate (2015-2020)
7.7 Australia Methylphenidate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Methylphenidate Sales, Revenue and Market Share by Country
8.1.1 South America Methylphenidate Sales and Market Share by Country (2015-2020)
8.1.2 South America Methylphenidate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Methylphenidate Sales and Growth Rate (2015-2020)
8.3 Argentina Methylphenidate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Methylphenidate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Methylphenidate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Methylphenidate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Methylphenidate Sales and Growth Rate (2015-2020)
9.3 Turkey Methylphenidate Sales and Growth Rate (2015-2020)
9.4 Egypt Methylphenidate Sales and Growth Rate (2015-2020)
9.5 South Africa Methylphenidate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Methylphenidate Sales and Market Share by Type (2015-2020)
10.2 Global Methylphenidate Revenue and Market Share by Type (2015-2020)
10.3 Global Methylphenidate Price by Type (2015-2020)
11 Global Methylphenidate Market Segment by Application
11.1 Global Methylphenidate Sales Market Share by Application (2015-2020)
11.2 Global Methylphenidate Revenue Market Share by Application (2015-2020)
11.3 Global Methylphenidate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Methylphenidate Sales, Revenue and Growth Rate (2021-2025)
12.2 Methylphenidate Market Forecast by Regions (2021-2025)
12.2.1 North America Methylphenidate Market Forecast (2021-2025)
12.2.2 Europe Methylphenidate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Methylphenidate Market Forecast (2021-2025)
12.2.4 South America Methylphenidate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Methylphenidate Market Forecast (2021-2025)
12.3 Methylphenidate Market Forecast by Type (2021-2025)
12.3.1 Global Methylphenidate Sales Forecast by Type (2021-2025)
12.3.2 Global Methylphenidate Market Share Forecast by Type (2021-2025)
12.4 Methylphenidate Market Forecast by Application (2021-2025)
12.4.1 Global Methylphenidate Sales Forecast by Application (2021-2025)
12.4.2 Global Methylphenidate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Methylphenidate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Methylphenidate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Methylphenidate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Methylphenidate Major Business
Table 9. Pfizer Methylphenidate Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Methylphenidate Product and Services
Table 12. Pfizer Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Methylphenidate Major Business
Table 15. Sandoz Methylphenidate Total Revenue (USD Million) (2018-2019)
Table 16. Sandoz SWOT Analysis
Table 17. Sandoz Methylphenidate Product and Services
Table 18. Sandoz Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Teva Basic Information, Manufacturing Base and Competitors
Table 20. Teva Methylphenidate Major Business
Table 21. Teva Methylphenidate Total Revenue (USD Million) (2018-2019)
Table 22. Teva SWOT Analysis
Table 23. Teva Methylphenidate Product and Services
Table 24. Teva Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Methylphenidate Major Business
Table 27. Novartis Methylphenidate Total Revenue (USD Million) (2018-2019)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Methylphenidate Product and Services
Table 30. Novartis Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GSK Basic Information, Manufacturing Base and Competitors
Table 32. GSK Methylphenidate Major Business
Table 33. GSK Methylphenidate Total Revenue (USD Million) (2018-2019)
Table 34. GSK SWOT Analysis
Table 35. GSK Methylphenidate Product and Services
Table 36. GSK Methylphenidate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Methylphenidate Sales by Manufacturer (2018-2019) (K MT)
Table 38. Global Methylphenidate Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Methylphenidate Sales by Regions (2015-2020) (K MT)
Table 40. Global Methylphenidate Sales Market Share by Regions (2015-2020)
Table 41. Global Methylphenidate Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Methylphenidate Sales by Countries (2015-2020) (K MT)
Table 43. North America Methylphenidate Sales Market Share by Countries (2015-2020)
Table 44. North America Methylphenidate Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Methylphenidate Revenue Market Share by Countries (2015-2020)
Table 46. Europe Methylphenidate Sales by Countries (2015-2020) (K MT)
Table 47. Europe Methylphenidate Sales Market Share by Countries (2015-2020)
Table 48. Europe Methylphenidate Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Methylphenidate Sales by Regions (2015-2020) (K MT)
Table 50. Asia-Pacific Methylphenidate Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Methylphenidate Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Methylphenidate Sales by Countries (2015-2020) (K MT)
Table 53. South America Methylphenidate Sales Market Share by Countries (2015-2020)
Table 54. South America Methylphenidate Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Methylphenidate Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Methylphenidate Sales by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Methylphenidate Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Methylphenidate Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Methylphenidate Revenue Market Share by Countries (2015-2020)
Table 60. Global Methylphenidate Sales by Type (2015-2020) (K MT)
Table 61. Global Methylphenidate Sales Share by Type (2015-2020)
Table 62. Global Methylphenidate Revenue by Type (2015-2020) (USD Million)
Table 63. Global Methylphenidate Revenue Share by Type (2015-2020)
Table 64. Global Methylphenidate Sales by Application (2015-2020) (K MT)
Table 65. Global Methylphenidate Sales Share by Application (2015-2020)
Table 66. Global Methylphenidate Sales Forecast by Regions (2021-2025) (K MT)
Table 67. Global Methylphenidate Market Share Forecast by Regions (2021-2025)
Table 68. Global Methylphenidate Sales Forecast by Type (2021-2025) (K MT)
Table 69. Global Methylphenidate Market Share Forecast by Type (2021-2025)
Table 70. Global Methylphenidate Sales Forecast by Application (2021-2025)
Table 71. Global Methylphenidate Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Methylphenidate Picture
Figure 2. Global Sales Market Share of Methylphenidate by Type in 2019
Figure 3. Type 1 Picture
Figure 4. Type 2 Picture
Figure 5. Methylphenidate Sales Market Share by Application in 2018
Figure 6. Attention deficit hyperactivity disorder Picture
Figure 7. Narcolepsy Picture
Figure 8. Other Picture
Figure 9. Global Methylphenidate Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Methylphenidate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Methylphenidate Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Methylphenidate Sales Market Share by Manufacturer in 2019
Figure 30. Global Methylphenidate Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Methylphenidate Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Methylphenidate Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Methylphenidate Revenue Market Share by Regions (2015-2020)
Figure 37. Global Methylphenidate Revenue Market Share by Regions in 2018
Figure 38. North America Methylphenidate Sales and Growth Rate (2015-2020)
Figure 39. Europe Methylphenidate Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Methylphenidate Sales and Growth Rate (2015-2020)
Figure 41. South America Methylphenidate Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Methylphenidate Sales and Growth Rate (2015-2020)
Figure 43. North America Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Methylphenidate Sales Market Share by Countries (2015-2020)
Figure 45. North America Methylphenidate Sales Market Share by Countries in 2018
Figure 46. North America Methylphenidate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Methylphenidate Revenue Market Share by Countries in 2018
Figure 48. United States Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Methylphenidate Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Methylphenidate Revenue Market Share by Countries in 2019
Figure 54. Germany Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Methylphenidate Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Methylphenidate Revenue Market Share by Regions 2019
Figure 62. China Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Methylphenidate Sales Market Share by Countries in 2019
Figure 69. South America Methylphenidate Revenue Market Share by Countries in 2019
Figure 70. Brazil Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Methylphenidate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Methylphenidate Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Methylphenidate Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Methylphenidate Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Methylphenidate Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Methylphenidate Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Methylphenidate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Methylphenidate Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Methylphenidate Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Methylphenidate Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Methylphenidate Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Methylphenidate Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
注意欠陥多動性障害（ADHD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Attention Deficit Hyperactivity Disorder (ADHD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…- 甲状腺ホルモン障害薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Thyroid Hormone Disorder Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Thyroid Hormone…
- γ-アミノ酪酸受容体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gamma-Aminobutyric Acid Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gamma-Aminob…
- ムスカリン性アセチルコリン受容体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Muscarinic Acetylcholine Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Muscarinic …
- 5-ヒドロキシトリプタミン受容体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global 5-Hydroxytryptamine Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 5-Hydroxytryptam…